Header Logo

Connection

Taha Al-Juhaishi to Humans

Back to Details
This is a "connection" page, showing publications Taha Al-Juhaishi has written about Humans.
Taha Al-Juhaishi
Connection Strength
0.514
Humans
  1. Treatment of Acute Myeloid Leukemia in the Community Setting. Oncologist. 2024 Sep 06; 29(9):801-805.
    View in: PubMed
    Score: 0.053
  2. Management of limited-stage Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2023 Dec 08; 2023(1):500-509.
    View in: PubMed
    Score: 0.050
  3. Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2023 05; 23(5):379-384.
    View in: PubMed
    Score: 0.048
  4. Survival Time in Hematologic Malignancies Obeys Newcomb-Benford Law. Mayo Clin Proc. 2022 02; 97(2):419-420.
    View in: PubMed
    Score: 0.044
  5. CAR-T in B-Cell Lymphomas: The Past, Present, and Future. Clin Lymphoma Myeloma Leuk. 2022 04; 22(4):e261-e268.
    View in: PubMed
    Score: 0.043
  6. Outcomes of cardiac diffuse large B-cell lymphoma (DLBCL) in the rituximab era. Int J Cardiol. 2021 Sep 15; 339:146-149.
    View in: PubMed
    Score: 0.043
  7. Selecting the Optimal CAR-T for the Treatment of B-Cell Malignancies. Curr Hematol Malig Rep. 2021 02; 16(1):32-39.
    View in: PubMed
    Score: 0.042
  8. Perspectives on chemotherapy for the management of double-hit lymphoma. Expert Opin Pharmacother. 2020 Apr; 21(6):653-661.
    View in: PubMed
    Score: 0.039
  9. Therapy-related myeloid neoplasms in lymphoma survivors: Reducing risks. Best Pract Res Clin Haematol. 2019 03; 32(1):47-53.
    View in: PubMed
    Score: 0.036
  10. Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation. Am J Hematol. 2025 Jun; 100(6):987-997.
    View in: PubMed
    Score: 0.014
  11. Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation. Europace. 2023 May 19; 25(5).
    View in: PubMed
    Score: 0.012
  12. Reported Pericardial Toxicities Associated with Acute Myelogenous Leukemia Treatments: A Pharmacovigilance Analysis of the FDA Adverse Reporting Database. Curr Probl Cardiol. 2022 11; 47(11):101345.
    View in: PubMed
    Score: 0.012
  13. Trends and disparities in pulmonary embolism mortality among patients with cancer. Vasc Med. 2022 10; 27(5):493-495.
    View in: PubMed
    Score: 0.011
  14. Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center. Bone Marrow Transplant. 2022 06; 57(6):1025-1027.
    View in: PubMed
    Score: 0.011
  15. Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance. Leuk Lymphoma. 2022 03; 63(3):710-721.
    View in: PubMed
    Score: 0.011
  16. Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas. Blood Adv. 2020 09 08; 4(17):4256-4266.
    View in: PubMed
    Score: 0.010
  17. Marginal Zone Lymphoma: State-of-the-Art Treatment. Curr Treat Options Oncol. 2019 12 05; 20(12):90.
    View in: PubMed
    Score: 0.010
  18. Prognostic Factors of Malignant Pheochromocytoma and Paraganglioma: A Combined SEER and TCGA Databases Review. Horm Metab Res. 2019 Jul; 51(7):451-457.
    View in: PubMed
    Score: 0.009
  19. Incidence of Lung Cancer among Young Women. N Engl J Med. 2018 09 06; 379(10):988-9.
    View in: PubMed
    Score: 0.009
  20. Cardiovascular disease research activity in the Middle East: a bibliometric analysis. Ther Adv Cardiovasc Dis. 2015 Jun; 9(3):70-6.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.